# BRIDION
> **NDA022225** · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2015-12-15
## Drug
- **FDA Application Number:** NDA022225
- **Application type:** New Drug Application
- **Brand name:** BRIDION
- **Generic name:** SUGAMMADEX
- **Active ingredients:** SUGAMMADEX SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MSD SUB MERCK
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2015-12-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022225)
---
*AI Analytics · CC0 1.0*